ADAR1 Capital Management »

Milestone Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $43k 28k 1.52
2024-06-30 $267k 203k 1.32
2024-03-31 $362k 203k 1.79

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Milestone Pharmaceuticals

BlackRock
Rtw Investments
Millennium Management
Alta Fundamental Advisers
Citadel Advisors
OrbiMed Advisors
Nantahala Capital Management
Lion Point Capital
Goldman Sachs Group
Bleichroeder
BML Capital Management
Stonepine Capital Management
Ikarian Capital
Altium Capital Management
Boxer Capital

View all funds holding Milestone Pharmaceuticals